Clinical trial • Not applicable • Neurology
stem cell-derived dopamine neurons for Parkinson's disease
Not applicable trial of stem cell-derived dopamine neurons for Parkinson's disease. 4 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Parkinson's disease
- Trial Stage
- Not applicable
- Drug Modality
- Cell therapy
Key dates
- Initial CTIS Submission Date
- 20-11-2024
- First CTIS Authorization Date
- 02-12-2024
Trial design
Not applicable trial across 1 site in Sweden.
- Target Sample Size
- 4
Eligibility
Recruits 4 Vulnerable population selected (isVulnerablePopulationSelected = true). No details on consent or assent handling provided in the record..
- Vulnerable Population
- Vulnerable population selected (isVulnerablePopulationSelected = true). No details on consent or assent handling provided in the record.
Recruitment
- Planned Sample Size
- 4
- Recruitment Window Months
- 60
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 4
Sweden
- Earliest CTIS Part Ii Submission Date
- 31-01-2024
- Latest Decision Or Authorization Date
- 02-12-2024
- Processing Time Days
- 306
- Number Of Sites
- 1
- Number Of Participants
- 4
Sites
- Site Name
- Region Skane Skanes Universitetssjukhus
- Department Name
- Neurology Clinic
- Contact Person Name
- Gesine Paul-Visse
- Contact Person Email
- gesine.paul-visse@med.lu.se
- Number Of Participants
- 4
Sponsor
Primary sponsor
- Full Name
- Region Skane
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Sweden
Investigational products
- Investigational Product Name
- transplanted stem cell-derived dopamine neurons
- Active Substance
- stem cell-derived dopamine neurons
- Modality
- Cell therapy
- Routes Of Administration
- intracerebral (into the brain)
- Route
- intracerebral (into the brain)
Related trials
Other published trials that may interest you.